News | November 24, 2014

Gamma Medica to Now Offer Philips MicroDose SI for a More Comprehensive Breast Cancer Solution

LumaGEM and MicroDose SI will bolster breast imaging suites’ screening offering in North America

Gamma Medica announced the company now offers Philips MicroDose SI, the first full-field digital mammography (FFDM) system that supports single-shot, non-invasive spectral imaging, as a complement to its market leading LumaGEM Molecular Breast Imaging (MBI) system. LumaGEM is a highly effective and cost-efficient technology for detecting breast cancer in patients with complex mammograms and dense breast tissue. The agreement with Philips will enable Gamma Medica to provide breast imaging suites with the option to purchase both technologies and offer the most advanced and safest commercially available dense breast solution for women. Philips will continue selling MicroDoseSI directly to customers.

Philips MicroDose mammography SI delivers outstanding image quality and non-invasive spectral applications in one fast and comfortable low-dose mammogram.

For those 40 percent of U.S. women who have dense breast tissue and those who have received inconclusive mammography results, the LumaGEM used as a secondary imaging tool is highly sensitive in its ability to detect lesions as small as five millimeters. As a functional imaging modality, it is also highly specific, resulting in fewer “false positives” and higher true positive biopsy rates compared to anatomical imaging methods such as ultrasound and MRI.

Breast tissue density has been linked to an increased risk of breast cancer and also decreases the sensitivity of mammography which impacts early detection.  Thirty-five percent of breast cancer goes undetected by mammography in women with dense breasts, as dense tissue masks the appearance of tumors.

“Gamma Medica is very excited to be working closely with Philips in an effort to provide women with the best technology options for breast cancer screening. Together, the LumaGEM and Philips MicroDose SI are the solution for increasing patient satisfaction and improving patient outcomes while lowering the overall cost of breast cancer treatment,” said Jim Calandra, president and chief executive officer of Gamma Medica. “The opportunity for imaging suites to have two leading breast cancer detection technologies under one roof will help revolutionize the future of breast cancer care.”

“Like Philips, Gamma Medica has taken a proactive approach to the growing industry demand and increasing regulatory pressure for low dose solutions,” said Richard Fabian, vice president, Imaging Systems Marketing, of Philips Healthcare. “MicroDose SI is just one of a range of Philips low-dose solutions that provide clinicians with the data and insights they need to make a definitive diagnosis while avoiding unnecessary exposure to radiation.”

For more information: www.gammamedia.com

Related Content

Hologic Opens Learning and Experience Centre in Zaventem, Belgium
News | Women's Health | March 21, 2019
Hologic Inc. opened its first Learning and Experience Centre in Zaventem, Belgium. The state-of-the-art facility...
QTbreasthealth Opens Breast Imaging Center in San Jose
News | Ultrasound Women's Health | March 20, 2019
QTbreasthealth has opened a new center in San Jose, Calif. The new location is now open and booking appointments for...
Older Biologic Age Linked to Elevated Breast Cancer Risk
News | Women's Health | March 19, 2019
Biologic age, a DNA-based estimate of a person’s age, is associated with future development of breast cancer, according...
PET Scans Show Biomarkers Could Spare Some Breast Cancer Patients from Chemotherapy
News | PET Imaging | March 18, 2019
A new study positron emission tomography (PET) scans has identified a biomarker that may accurately predict which...
Fujifilm Launches Three New Software Tools for Aspire Cristalle Digital Mammography System
Technology | Mammography | March 15, 2019
Fujifilm Medical Systems USA announced it has fulfilled all U.S. Food and Drug Administration (FDA) regulatory...
Hologic Receives CE Mark for Three-in-One Omni Hysteroscope
News | Endoscopes | March 14, 2019
Hologic Inc. announced it has received a CE mark in Europe for its Omni hysteroscope, a three-in-one modular scope with...
CT, Mammograms Offer Clues to Preventing Heart Problems After Cancer Treatment
News | Cardio-oncology | March 13, 2019
An imaging procedure commonly performed before starting cancer treatment can provide valuable clues about a patient's...
Sponsored Content | Videos | Artificial Intelligence | March 13, 2019
At RSNA 2018, iCad showed how its...
Hologic Earns CE Mark for LOCalizer Wireless Breast Lesion Localization System
News | Breast Imaging | March 07, 2019
Hologic Inc. announced the granting of a CE Mark to the LOCalizer wireless radio frequency identification (RFID) breast...
South Dakota's Density Inform Bill Signed Into Law
News | Breast Density | March 06, 2019
With the passage of HB1124, South Dakota becomes the 37th state with breast density inform legislation. The law, which...